Heart Disease and Myocardial Infarction

Figures from the World Health Organisation show that heart disease is the leading cause of death worldwide. In the past this was thought to be a problem mainly for western countries. But the burden of disease is now growing rapidly in developing nations so that around the world somebody dies from coronary heart disease approximately every 4 seconds. Many people die suddenly often without any previous symptoms of heart disease.

The most common cause of death is myocardial infarction (MI), which is often referred to as a heart attack. Another term for this is coronary thrombosis because a blood clot (thrombus) forms in one of the blood vessels of the heart (coronary arteries). This causes a blockage that stops the flow of blood to the heart muscle. Starved of oxygen the heart muscle starts to die and the heart may stop pumping – with fatal consequences.

For those who receive life-saving medical care, treatment is often medicines to dissolve the blood clot (so called clot-busting thrombolytic enzymes), or mechanical re-opening of the artery using a balloon-tipped catheter (angioplasty). Although restoring the flow of blood is essential to minimise the the death of heart tissue, suddenly enabling blood to flow again through the heart muscle (reperfusion) can cause additional injury through the formation of reactive oxygen metabolites and excessive inflammation. This damage can leave the heart muscle permanently scarred, which decreases the ability of the heart to pump efficiently and leads to heart failure.

There is a pressing need to find new medicines that reduce the occurrence of myocardial infarction and prevent the damage caused by reperfusion injury.

The William Harvey Research Foundation urgently needs funds to continue its support of research to discover (i) new therapies to protect the heart form reperfusion injury, (ii) improved cardioprotective solutions for use during heart surgery or heart transplant, and (iii) for stem cell research for repairing tissue after reperfusion injury and restoring the function of heart muscle.

 
News - The Foundation - Research Programmes - The Institute - PhD & Research - William Harvey - Sir John Vane - Support Our Research - Contact